MolGen announced last Wednesday that it has acquired Dutch automation company Synchron Instrumenten BV, also known as Synchron Lab Automation. With this acquisition MolGen will expand its existing portfolio and its ability to build high-end automation solutions for...
MolGen Showcases its Diagnostics Automation Solution at ESCV 2022 in Manchester
Veenendaal, September 6, 2022 - MolGen B.V. of Veenendaal (NL), a global solutions provider in DNA/RNA technology of hardware, reagents, consumables, software and service for human and animal diagnostics, the agriculture and biotech industries, participates in the...
MolGen Showcases its Lab Automation Solutions at AACC in Chicago
The AACC Fair is one of the world’s most important international scientific and medical events for clinical laboratory technologies and research. Researchers from over 200 companies specialised in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management are to showcase their products and innovations in the clinical chemistry field. MolGen is present with its automation solutions in clinical laboratory science.
MolGen Showcases Automated High Throughput Laboratory Solutions at the Analytica Fair in Munich
Veenendaal, June 8th, 2022 - MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA/RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the Analytica Fair, in Munich, on the 21st- 24th of June 2022.
MolGen Takes Part at SLAS Europe Fair in Dublin, Ireland
MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA / RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the SLAS Europe Fair, in Dublin, on the 24-27th of May 2022.
Multiplex Respiratory viruses’ RT-qPCR kit: MoaA RT-q PCR kit by MolGen
The rapid and global spread of SARS-CoV-2 has impacted society heavily. This pandemic has placed both the world economy and health under pressure. To provide relief to populations, governments and businesses during these difficult times, MolGen has developed a high throughput, efficient and safe testing framework.
MolGen to participate at the 32nd European congress of clinical microbiology & infectious diseases taking place in Lisbon, Portugal
MolGen b.v. of Veenendaal (NL) a single-source supplier of DNA/RNA workflows containing hardware, consumables, reagents, software and services for the agriculture and biotechnology is putting the final touches on its preparation for its attendance at the 32nd ECCMID on April 23-26. The company’s presence at this premier event is particularly worth noting as it will serve as the introduction of MolGen’s revolutionary MoaA RT-q PCR kit.
High quality DNA/RNA extraction kits for efficient high throughput testing
Veenendaal, April 4th, 2022 - The rapid spread of SARS-CoV-2 has heavily impacted global society with high pressure of COVID-19 on public health and economics. MolGen is very proud to have assisted in relieving some of the pressure and support the testing framework....
MolGen to participate at AGBT Agriculture meeting in Loew Coronado
MolGen b.v. of Veenendaal (NL) is getting ready to attend the AGBT Agriculture Meeting, April 4 – 6. The AGBT Agricultural Meeting brings together top leaders and global researchers to discuss the unique challenges facing agriculture and genomics.
MolGen to participate at Crop Innovation & Business Fair in Ghent
MolGen b.v. of Veenendaal (NL) is preparing to attend the CROP Innovation & Business Fair, March 27 – 29. As a C-level conference for management, entrepreneurs, leading scientists and investors, Crop Innovation & Business brings together the best and brightest of the international Ag-Bio community.